CRISPR Therapeutics Ownership & Insider Activity

CRISPR Therapeutics (CRSP) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.7% of shares outstanding. Institutional investors hold 61.3%.

Shares Outstanding

96.693M

Shares Float

84.454M

Insider Shares Owned

1.719M

Insider % Owned

1.7%

Institutional Shares Held

59.264M

Institutional % Held

61.3%

Ownership Breakdown

Net Insider Activity by Month

CRISPR Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
May 28, 2026	Naimish Patel	CHIEF MEDICAL OFFICER	SELL-OPTIONS	6.214K	$55.62	$211K
Mar 20, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	3.068K	$46.78	$149K
Mar 20, 2026	Samarth Kulkarni	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	9.667K	$46.78	$469K
Mar 20, 2026	Raju Prasad	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	2.542K	$46.78	$173K
Mar 14, 2026	Naimish Patel	CHIEF MEDICAL OFFICER	SELL-OPTIONS	4.975K	$48.26	$152K
Mar 14, 2026	Raju Prasad	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	6.256K	$48.26	$476K
Mar 14, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	3.425K	$48.26	$166K
Mar 14, 2026	Samarth Kulkarni	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	10.276K	$48.26	$499K
Mar 10, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	2.700K	$52.80	$148K
Mar 10, 2026	Samarth Kulkarni	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	9.452K	$52.80	$517K

Date	Member	Party	Chamber	Action	Amount
Sep 20, 2021	Thomas R. Suozzi	D	House	S	$50,001 - $100,000